首页> 外文OA文献 >Insulin glargine utilization in real-life-efficacy of a regimen based on insulin glargine in patients with type 2 diabetes previously on nph insulin in clinical practice in Spain

【2h】

Insulin glargine utilization in real-life-efficacy of a regimen based on insulin glargine in patients with type 2 diabetes previously on nph insulin in clinical practice in Spain

机译：在西班牙的临床实践中，在以前使用nph胰岛素的2型糖尿病患者中，以甘精胰岛素为基础的方案在实际生活中使用甘精胰岛素的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Delgado Álvarez, Elías;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: Evidence from clinical practice in Spain [J] . DelgadoE. International journal of clinical practice . 2012,第3期

机译：以前接受NPH胰岛素治疗的2型糖尿病患者使用甘精胰岛素治疗的结果：来自西班牙临床实践的证据
2. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTI [J] . Meneghini LF, Rosenberg KH, Koenen C, Diabetes, obesity & metabolism . 2007,第3期

机译：地特胰岛素改善了血糖控制水平，降低了低血糖症，并且在未接受胰岛素治疗或接受NPH或甘精胰岛素治疗的2型糖尿病患者中均无体重增加：德国PREDICTI小组的临床实践经验
3. Comparison of insulin glargine versus NPH insulin in people with Type 2 diabetes mellitus under outpatient-clinic conditions for 18 months using a basal-bolus regimen with a rapid-acting insulin analogue as mealtime insulin. [J] . Siegmund T, Weber S, Blankenfeld H, Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association . 2007,第6期

机译：使用快速反应的胰岛素类似物作为进餐时胰岛素的基础推注方案比较门诊患者在18个月的2型糖尿病患者中的甘精胰岛素和NPH胰岛素。
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain [O] . E Delgado -1

机译：以前接受NPH胰岛素治疗的2型糖尿病患者使用甘精胰岛素治疗的结果：来自西班牙临床实践的证据
7. PDB66 INSULIN GLARGINE UTILIZATION IN REAL-LIFE—EFFICACY OF A REGIMEN BASED ON INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES PREVIOUSLY ON NPH INSULIN IN CLINICAL PRACTICE IN SPAIN [O] . Delgado E 2008

机译：PDB66胰岛素在实际生活中的使用—基于胰岛素亮白的方案在以前以NPH胰岛素为基础的2型糖尿病患者中的临床应用在西班牙

Insulin glargine utilization in real-life-efficacy of a regimen based on insulin glargine in patients with type 2 diabetes previously on nph insulin in clinical practice in Spain

著录项

相似文献

相关主题

期刊订阅